{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:59:20Z","timestamp":1791165560133,"version":"4.1.0"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Individuals with systemic lupus erythematosus (SLE) have an increased risk of pregnancy-related complications. However, data on acute cardiovascular complications during delivery admissions remain limited.<\/jats:p><\/jats:sec>Objective<\/jats:title>To investigate whether SLE is associated with an increased risk of acute peripartum cardiovascular complications during delivery hospitalization among individuals giving birth.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This population-based cross-sectional study was conducted with data from the National Inpatient Sample (2004-2019) by using International Classification of Diseases, Ninth Revision, Clinical Modification <\/jats:italic>(ICD-9-CM<\/jats:italic>) or International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Clinical Modification <\/jats:italic>(ICD-10-CM<\/jats:italic>) codes to identify delivery hospitalizations among birthing individuals with a diagnosis of SLE. A multivariable logistic regression model was developed to report an adjusted odds ratio (OR) for the association between SLE and acute peripartum cardiovascular complications. Data were analyzed from May 1 through September 1, 2022.<\/jats:p><\/jats:sec>Exposure<\/jats:title>Diagnosed SLE.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Primary study end points were preeclampsia, peripartum cardiomyopathy, and heart failure. Secondary end points included ischemic and hemorrhagic stroke, pulmonary edema, cardiac arrhythmias, acute kidney injury (AKI), venous thromboembolism (VTE), length of stay, and cost of hospitalization.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 63\u202f115\u202f002 weighted delivery hospitalizations (median [IQR] age, 28 [24-32] years; all were female patients) were identified, of which 77\u202f560 hospitalizations (0.1%) were among individuals with SLE and 63\u202f037\u202f442 hospitalizations (99.9%) were among those without SLE. After adjustment for age, race and ethnicity, comorbidities, insurance, and income level, SLE remained an independent risk factor associated with peripartum cardiovascular complications, including preeclampsia (adjusted OR [aOR], 2.12; 95% CI, 2.07-2.17), peripartum cardiomyopathy (aOR, 4.42; 95% CI, 3.79-5.13), heart failure (aOR, 4.06; 95% CI, 3.61-4.57), cardiac arrhythmias (aOR, 2.06; 95% CI, 1.94-2.21), AKI (aOR, 7.66; 95% CI, 7.06-8.32), stroke (aOR, 4.83; 95% CI, 4.18-5.57), and VTE (aOR, 6.90; 95% CI, 6.11-7.80). For resource use, median (IQR) length of stay (3 [2-4] days vs 2 [2-3] days; P<\/jats:italic>\u2009&amp;lt;\u2009.001) and cost of hospitalization ($4953 [$3305-$7517] vs $3722 [$2606-$5400]; P<\/jats:italic>\u2009&amp;lt;\u2009.001) were higher for deliveries among individuals with SLE.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>This study found that SLE was associated with increased risk of complications, including preeclampsia, peripartum cardiomyopathy, heart failure, arrhythmias, AKI, stroke, and VTE during delivery hospitalization and an increased length and cost of hospitalization.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.43388","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T16:30:39Z","timestamp":1669739439000},"page":"e2243388","source":"Crossref","is-referenced-by-count":26,"title":["Analysis of Cardiovascular Complications During Delivery Admissions Among Patients With Systemic Lupus Erythematosus, 2004-2019"],"prefix":"10.1001","volume":"5","author":[{"given":"Salman","family":"Zahid","sequence":"first","affiliation":[{"name":"Department of Medicine, Sands-Constellation Heart Institute, Rochester General Hospital, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sands-Constellation Heart Institute, Rochester General Hospital, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Wassif","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noreen T.","family":"Nazir","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Illinois at Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadiya S.","family":"Khan","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin D.","family":"Michos","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,11,29]]},"reference":[{"key":"zoi221223r1","doi-asserted-by":"publisher","first-page":"i3","DOI":"10.1093\/rheumatology\/kew401","article-title":"Systemic lupus erythematosus diagnosis and management.","volume":"56","author":"Thong","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"zoi221223r2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.","volume":"82","author":"Cervera","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"zoi221223r3","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/rheumatology\/kep062","article-title":"Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years.","volume":"48","author":"Chambers","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"zoi221223r4","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/BF01451283","article-title":"A multicentre study of 513 Danish patients with systemic lupus erythematosus: II: disease mortality and clinical factors of prognostic value.","volume":"17","author":"Jacobsen","year":"1998","journal-title":"Clin Rheumatol"},{"issue":"2","key":"zoi221223r5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3109\/08916934.2013.856005","article-title":"Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.","volume":"47","author":"Gustafsson","year":"2014","journal-title":"Autoimmunity"},{"issue":"2","key":"zoi221223r6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U","article-title":"Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus.","volume":"42","author":"Ward","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"1","key":"zoi221223r7","first-page":"70","article-title":"Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors.","volume":"34","author":"Urowitz","year":"2007","journal-title":"J Rheumatol"},{"issue":"2","key":"zoi221223r8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9343(76)90431-9","article-title":"The bimodal mortality pattern of systemic lupus erythematosus.","volume":"60","author":"Urowitz","year":"1976","journal-title":"Am J Med"},{"issue":"1","key":"zoi221223r9","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000467","article-title":"Cardiovascular complications of systemic lupus erythematosus: impact of risk factors and therapeutic efficacy-a tertiary centre experience in an Appalachian state.","volume":"8","author":"McVeigh","year":"2021","journal-title":"Lupus Sci Med"},{"issue":"1","key":"zoi221223r10","first-page":"32","article-title":"Prevalence of and risk factors for the metabolic syndrome in women with systemic lupus erythematosus.","volume":"26","author":"Bultink","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"zoi221223r11","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1007\/s10067-021-05850-0","article-title":"Polycystic ovary syndrome: epidemiologic assessment of prevalence of systemic rheumatic and autoimmune diseases.","volume":"40","author":"Sharmeen","year":"2021","journal-title":"Clin Rheumatol"},{"key":"zoi221223r12","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108637","article-title":"Association of cardiometabolic risk status with clinical activity and damage in systemic lupus erythematosus patients: a cross-sectional study.","volume":"222","author":"Campos-L\u00f3pez","year":"2021","journal-title":"Clin Immunol"},{"issue":"2","key":"zoi221223r13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/157340308784245775","article-title":"Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors.","volume":"4","author":"Zeller","year":"2008","journal-title":"Curr Cardiol Rev"},{"issue":"8","key":"zoi221223r14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/eurheartj\/ehu403","article-title":"Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions.","volume":"36","author":"Mason","year":"2015","journal-title":"Eur Heart J"},{"key":"zoi221223r15","article-title":"Polycystic ovary syndrome may be an autoimmune disorder.","volume":"2016","author":"Mobeen","year":"2016","journal-title":"Scientifica (Cairo)"},{"issue":"5","key":"zoi221223r16","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.fertnstert.2022.03.009","article-title":"Polycystic ovary syndrome: a \u201crisk-enhancing\u201d factor for cardiovascular disease.","volume":"117","author":"Guan","year":"2022","journal-title":"Fertil Steril"},{"issue":"16","key":"zoi221223r17","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019797","article-title":"Maternal and fetal complications associated with systemic lupus erythematosus: an updated meta-analysis of the most recent studies (2017-2019).","volume":"99","author":"He","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"zoi221223r18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.semarthrit.2020.01.014","article-title":"Maternal and perinatal outcomes of pregnancies in systemic lupus erythematosus: a nationwide population-based study.","volume":"50","author":"Chen","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"zoi221223r22","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2215\/CJN.00240110","article-title":"A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis.","volume":"5","author":"Smyth","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"zoi221223r23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003432","article-title":"Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study.","volume":"17","author":"Pujades-Rodriguez","year":"2020","journal-title":"PLoS Med"},{"issue":"6","key":"zoi221223r24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/CS20150702","article-title":"The role of inflammation in the pathology of preeclampsia.","volume":"130","author":"Harmon","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"zoi221223r25","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3864941","article-title":"The role of inflammation in the pathogenesis of preeclampsia.","volume":"2020","author":"Michalczyk","year":"2020","journal-title":"Mediators Inflamm"},{"key":"zoi221223r27","article-title":"The use of glucocorticoids in lupus nephritis: new pathways for an old drug.","volume":"8","author":"Mej\u00eda-Vilet","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"zoi221223r28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0002-9343(92)90578-Y","article-title":"Risk factors for coronary artery disease in patients with systemic lupus erythematosus.","volume":"93","author":"Petri","year":"1992","journal-title":"Am J Med"},{"key":"zoi221223r29","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100657","article-title":"Concerning trends in maternal risk factors in the United States: 1989-2018.","volume":"29-30","author":"Bornstein","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"4","key":"zoi221223r30","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015123","article-title":"Cardiovascular health among pregnant women, aged 20 to 44 years, in the United States.","volume":"9","author":"Perak","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"zoi221223r31","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/HYPERTENSIONAHA.121.17104","article-title":"Racial disparities in cardiovascular complications with pregnancy-induced hypertension in the United States.","volume":"78","author":"Minhas","year":"2021","journal-title":"Hypertension"},{"issue":"3","key":"zoi221223r32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacadv.2022.100062","article-title":"Racial and socioeconomic disparities in cardiovascular outcomes of preeclampsia hospitalizations in the United States 2004-2019.","volume":"1","author":"Zahid","year":"2022","journal-title":"JACC Adv"},{"issue":"5","key":"zoi221223r33","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/HCO.0000000000000893","article-title":"Impact of social determinants of health on cardiovascular disease prevention.","volume":"36","author":"Mannoh","year":"2021","journal-title":"Curr Opin Cardiol"},{"key":"zoi221223r34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2021.100286","article-title":"Income disparity and utilization of cardiovascular preventive care services among U.S. adults.","volume":"8","author":"Shahu","year":"2021","journal-title":"Am J Prev Cardiol"},{"issue":"18","key":"zoi221223r35","doi-asserted-by":"crossref","first-page":"419","DOI":"10.15585\/mmwr.mm6818a4","article-title":"Racial disparities in mortality associated with systemic lupus erythematosus\u2014Fulton and DeKalb counties, Georgia, 2002-2016.","volume":"68","author":"Lim","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"21","key":"zoi221223r36","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi221223r37","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1177\/0961203316676641","article-title":"Hospitalization of patients with systemic lupus erythematosus is a major cause of direct and indirect healthcare costs.","volume":"26","author":"Anandarajah","year":"2017","journal-title":"Lupus"},{"issue":"20","key":"zoi221223r38","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1001\/jama.2017.17653","article-title":"Adherence to methodological standards in research using the National Inpatient Sample.","volume":"318","author":"Khera","year":"2017","journal-title":"JAMA"},{"key":"zoi221223r19","doi-asserted-by":"crossref","DOI":"10.15620\/cdc:113967","volume-title":"Maternal Mortality Rates in the United States, 2020","author":"Hoyert","year":"2022"},{"key":"zoi221223r26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-3-030-98824-1_13","volume-title":"Cardiovascular Risk Assessment in Primary Prevention","author":"Quispe","year":"2022"},{"key":"zoi221223r20","unstructured":"Agency for Healthcare Research and Quality. Overview of the National (Nationwide) Inpatient Sample (NIS). Healthcare Cost and Utilization Project. Accessed May 16, 2022. https:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp"},{"key":"zoi221223r21","unstructured":"Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project (HCUP). Accessed May 21, 2022. https:\/\/www.ahrq.gov\/data\/hcup\/index.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2799028\/zahid_2022_oi_221223_1668781443.13953.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T16:30:58Z","timestamp":1669739458000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2799028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.43388","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,29]]}}}